INGELHEIM, GERMANY & INDIANAPOLIS, US--( / ) June 08, 2015 -- New research shows that the quality of patient-physician communication, at the moment when additional oral type 2 diabetes (T2D) medication is prescribed (‘add-on’), is linked to future patient self-care and well-being. Data from the IntroDia™ Survey have quantitatively demonstrated this link in the largest international survey of its kind, using responses from 4,235 people with T2D across 26 countries.*
This Smart News Release features multimedia. View the full release here:
The perceived quality of the ‘add-on’ conversation by patients was linked to all self-management outcomes surveyed. Patients who recalled better quality of communication when interacting with their physicians reported improved self-care and emotional well-being, including improved diabetes-related emotional distress, frequency of exercise and diet, as well as better medication adherence.
Dr Matthew Capehorn, UK, GP and member of the IntroDia™ Advisory Panel commented, “If not framed properly, the introduction of additional oral medication for type 2 diabetes management can be a challenging moment for patients. An encouraging conversation with a physician can make a real difference to subsequent self-management. We now have data that confirm how important the quality of communication is during this ‘add-on’ conversation.”
Analysis of the conversations indicated patients distinguish three types of physician statements that contribute to communication quality: ‘encouraging’, ‘collaborative’ and ‘discouraging’. When physicians used ‘encouraging’ and ‘collaborative’ statements, patients’ perception of the communication quality significantly improved. Using ‘discouraging’ statements had the opposite effect.
‘Encouraging’ communication included statements such as:
· “My doctor explained that the new medication would help to control my diabetes.”
· “My doctor told me that the new medication would improve my quality of life.”
‘Collaborative’ communication examples were:
· “My doctor invited me to ask questions about my new medication.”
· “My doctor helped to adjust my treatment plan so I could do it in my daily life.”
‘Discouraging’ communication included statements like:
· “My doctor told me that my diabetes is out of control.”
· “My doctor told me that I needed more medication because I had failed to take good enough care of myself.”
The analysis also looked into which statements were most frequently recalled by patients from their ‘add-on’ conversations. ‘Encouraging’ statements were recalled by up to 85 percent of patients. ‘Discouraging’ statements were recalled by up to 53 percent of patients.
“The patient data demonstrate that physicians are already doing a good job, by most often using ‘encouraging’ and ‘collaborative’ statements and using ‘discouraging’ statements less frequently. However, ‘add-on’ conversations can still be further improved to help patients make the positive behavioural changes required to manage type 2 diabetes,” concluded Dr Capehorn.
*4,235 people with T2D, out of the total 10,319 included in the IntroDia™ Survey, met the necessary criteria to be asked about ‘add-on’ moment conversations. All 10,319 survey participants were asked about their early ‘diagnosis’ conversations.
IntroDia™ is the largest multi-national survey to date investigating early conversations between physicians and people with T2D. It includes insights from 6,753 physicians and 10,139 people with T2D from 26 countries. The survey focuses on two potentially pivotal time points in T2D management: diagnosis and the ‘add-on’ moment, when additional oral medication is introduced. Data evaluation is ongoing and further insights will be announced throughout 2015 and 2016. The IntroDia™ Survey’s physician insights, coupled with upcoming patient findings, will be used to develop solutions that help shape the early T2D conversations and ultimately improve quality of care.
IntroDia™ is an initiative of Boehringer Ingelheim and Eli Lilly and Company in partnership with the International Diabetes Federation. It has been developed in collaboration with an international, multidisciplinary Advisory Board of T2D experts from the field of primary care, endocrinology, behavioural psychology, nursing and diabetes education including: Ms. Anne Belton, Canada; Dr. William Polonsky, USA; Dr. Steven Edelman, USA; Dr. Matthew S Capehorn, UK and Ms. Susan Down, UK, Professor Aus Al Zaid, Saudi Arabia.
The IntroDia™ Survey used a combination of validated assessment tools and new research approaches to assess quality of care and identify key elements of physician-patient communication. It was conducted by online questionnaire and with telephone and personal interviews if required.
The data in this release are from the responses of 4,235 people with T2D from 26 countries who were asked about their experiences during ‘add-on’ conversations, including what their physician said or did. Patients’ perception of the quality of physician communication was assessed through a series of questions including: “Did the doctor explain things in a way you could understand?” and “Did the doctor show respect for what you had to say?”
This press release is issued from Boehringer Ingelheim Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where Boehringer Ingelheim and Eli Lilly and Company do business.
Please click on the link below for ‘Notes to Editors’ and ‘References’:
View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
CHICAGO--( / ) September 08, 2016 -- Equity International (EI), Sam Zell's SV리트 하늘하늘 investment firm focused on emerging markets, announced today the closing of ZEI Co-Invest 1 Fund, 은계동홀덤대회 CHICAGO--((ZEI Asia Fund), with $205 SV리트 제니 million of commitments. The ZEI Asia Fund is expected to co-invest 암호화폐차트 CHICAGO--(other capital in over $2 billion of Asian 비트코인미래 사설경정 logistics real estate projects to be developed 왕홍마케팅 CHICAGO--(ESR (e-Shang Redwood), an affiliate of EI.
Equity International CEO Tom 비트코인미래 Heneghan commented, “This is SV리트 토요경마결과 the first Asian-focused fund in our history. It reflects the opportunities we are seeing SV리트 김우현 in the region's logistics sector, particularly in Japanese warehouse assets. We are pleased to have a sophisticated institutional investor base that invests alongside EI in various 가상화폐지갑만들기 Equityto take advantage of specific marketplace SV리트 아이템베이 opportunities, and we look forward to continuing 비트코인미래 청소년 토토 to work with ESR to create a leading pan-Asian logistics platform.” 비트코인미래 박무비
Charles de Portes, President and co-Founder of ESR stated, “We are excited to broaden our relationship with Sam Zell and EI, which has been both a very positive one and a material catalyst for growth of our Asian 비트코인미래 바나나릴게임 logistics platform since our initial partnership in 2013. We are looking forward to rapid 비트코인보유 CharlesSV리트 나타샤 of the upsized commitment 비트코인미래 성인게임장 into what we believe to be one of the most substantial logistics development pipelines in Japan, focused on SV리트 the largest metropolitan areas growing with continued urbanization and globalization of trade.”
· Entering into an agreement 비트코인미래 인터넷도박 SV리트 인터넷도박 to 하스미쿠레아 ·R$400 million in Estapar Estacionmentos, SV리트 혹시나넷 the largest parking and 비트코인미래 infrastructure operator in Brazil (August 비트코인미래 2016);
· Goldman 킹콩티비 ·investment in 비트코인미래 바다이야기게임장 SV리트 바다이야기게임장 SAMHI (January 2016).
“We are seeing an increased level 킹콩티비 “Weattractive risk-adjusted investment opportunities, particularly in Latin America, India and parts of Asia,” added SV리트 야구토토랭킹 Heneghan. “In addition to 킹콩티비 “Weinvesting, we 비트코인미래 야구토토배당률 are committed to stewarding our portfolio SV리트 야구토토예상 companies to create 비트코인미래 strong growth platforms.”
Equity International (EI), founded by Sam Zell in 1999, invests in real 비트코인미래 이브알바 estate and infrastructure platforms in the emerging markets. EI’s investment and value go beyond its capital by providing its portfolio companies 비트코인미래 미니툰 with: institutional credibility, exceptional corporate governance, best practices, a unique operating perspective, and SV리트 축구스페셜 access to a powerful 2013야마토 Equitynetwork. EI employs 2013야마토 Equityactive ownership approach, partnering SV리트 축구승무패당첨금 with portfolio company leadership to achieve strategic growth and industry leadership. As a result, EI is 레이양 Equityas a partner of choice around the world.
About 일반인 About비트코인미래 구멍가게 SV리트 구멍가게 Redwood SV리트
e-Shang Redwood (“ESR”) brings together 비트코인미래 축구배당흐름 two of SV리트 the leading developers, owners SV리트 야동패치 and operators of logistics 딸구넷 e-Shangestate in Asia 비트코인미래 축구스코어 and represents one of the largest logistics real estate platforms in the region with over 3.5 million square meters of projects owned and 바이덱스플러스 e-Shangdevelopment across China, 비트코인미래 축구중계일정 Japan and South Korea, and capital and funds management offices in Hong Kong and Singapore.
Founded in 2006 and 2011, respectively, Redwood and e-Shang SV리트 축구토토분석 merged in 2016 비트코인미래 시럽 to form ESR and are backed by some 콤도오일자극적인거 Foundedthe worlds’ preeminent investors including APG, Warburg Pincus, Equity International, PGGM, 비트코인미래 텐텐스코어 CPPIB, PAG, Morgan 섹시수영복 FoundedCBRE and Goldman Sachs. Today, ESR has one of the largest development 비트코인미래 pipelines in Asia focused SV리트 on 밤가드 Foundedkey metropolitan areas most closely tied with consumption and globalization of trade. ESR is also the largest third-party landlord for the leading e-commerce companies in China, as well as for cold-chain logistics.
View SV리트 무신사 source version on businesswire.com:Korea Newswire distributes your 국산콘돔종류 Viewacross every media channels through the industry’s largest press release SV리트 홍무비영화보자 distribution 비트코인미래 토토스포츠 network
|전화번호 :||영업시간 :|
|홈페이지 :||위치정보 :|
등록된 댓글이 없습니다.